Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2008
08/28/2008US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080207607 Antiarthritic agents; antiinflammatory agents; arteriosclerosis; multiple sclerosis
08/28/2008US20080207606 Immunology diseases; analgesics; antiarthritic agents; cardiovascular disorders; antiischemic agents; skin disorders;antiulcer agents; bone disorders; antihistamines
08/28/2008US20080207565 Use of bisphosphonates for pain treatment
08/28/2008US20080207557 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia;
08/28/2008US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies
08/28/2008US20080207517 SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION
08/28/2008US20080207492 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders
08/28/2008US20080206360 Riboflavin (vitamin B2), extract of feverfew, magnesium, magnesium oxide, vitamin B6, B12, betaine, and plant derived phytochemicals
08/28/2008US20080206348 Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers
08/28/2008US20080206314 patches has pressure-sensitive adhesive matrix containing a polyisobutylene, free of permeation enhancer, for drug deliverying sufentanil through the skin to provide an analgesic effect, pain management; sustained release, side effect reduction, consistent concentration in blood
08/28/2008US20080206312 Therapeutic Morpholino-Substituted Compounds
08/28/2008US20080206267 Inactivation Of Genes Of The Mep Pathway
08/28/2008US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules
08/28/2008US20080206259 Unique and specific combinations of polyclonal anti-TNF and anti-IL-6 antibodies directed to cytokines; high-risk patients, including immunocompromised patients such as surgical and other hospitalized patients, low birth weight infants, and burn and trauma victims
08/28/2008US20080206213 Method for reducing or preventing systemic inflammation
08/28/2008US20080206212 Method for the utilization of and product containing inactivated probiotic
08/28/2008US20080206188 polyethylene glycol monomethyl ether or dimethyl ether, polyoxypropylene glycol; for an inflamed epithelium at risk of developing gut-derived sepsis from an intestinal pathogen; labeled package
08/28/2008US20080206161 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
08/28/2008DE102007009319A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
08/28/2008DE102007009125A1 Mittel zur Körper- oder Schönheitspflege Preparations for body and beauty care
08/28/2008DE102007008840A1 Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP) Novel polymorph of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy) -5- [4-methylsulfonyl) phenyl] -3 (2H) -pyridazinone (FHMP)
08/28/2008DE102007008839A1 Verfahren zur Herstellung von 4-(3-Hydroxy-3-methyl-butoxy)-5-[4-(methylsulfonyl)phenyl]-2-arylpyridazin-3(2H)-onen Process for the preparation of 4- (3-hydroxy-3-methyl-butoxy) -5- [4- (methylsulfonyl) phenyl] -2-arylpyridazin-3 (2H) -ones
08/28/2008CA2678691A1 4-(pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
08/28/2008CA2678147A1 Indole derivatives
08/28/2008CA2677565A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/27/2008EP1961811A1 Novel cytokine ZCYTOR17 ligand
08/27/2008EP1961759A1 Integrin targeted cyclopeptide ligands, their preparation and use
08/27/2008EP1961750A1 Vla-4 inhibitory drug
08/27/2008EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
08/27/2008EP1960406A2 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
08/27/2008EP1960400A1 Pyrazoloisoquinoline derivatives
08/27/2008EP1960398A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory
08/27/2008EP1960372A1 Kinase inhibitors and their uses
08/27/2008EP1960351A1 Propionamide compounds as antiinflammatory agents
08/27/2008EP1959988A1 Use of transferrins for treating destructive inflammation of mucous membrane
08/27/2008EP1708996B1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/27/2008EP1581474B1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
08/27/2008EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
08/27/2008EP1406895B1 Lactone formulations and method of use
08/27/2008EP1383386B1 Anti-inflammatory herbal composition
08/27/2008EP1337560B1 Truncated cd200
08/27/2008EP1234025B1 Human enzymes of the metalloprotease family
08/27/2008EP0949931B1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
08/27/2008CN101253199A Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
08/27/2008CN101253180A 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
08/27/2008CN101253178A Use of fused imidazole derivatives to mediate CCR3 related conditions
08/27/2008CN101252934A Prokineticin 1 receptor
08/27/2008CN101252923A Adhesive skin patch
08/27/2008CN101250206A Effective part containing cyaniding 3-O-glucoside as well as preparation method and use thereof
08/27/2008CN101249258A An uro-genital condition treatment system
08/27/2008CN101249256A Preparing method of medicament for curing severe rheumatic arthritis
08/27/2008CN101249234A Mongolian medicine for curing cold and method of preparing the same
08/27/2008CN101249224A Method for improving vitamin C Yinqiao tablet stability
08/27/2008CN101249220A Oral capsule for curing cervicobrachia, lumbodynia and leg pain and method of preparing the same
08/27/2008CN101249214A Xiabing arrowhead spray for curing various pain
08/27/2008CN101249205A Chinese medicine for curing cold and all lesion
08/27/2008CN101249203A Traditional Chinese medicine pills for curing acute and chronic waist-leg pain and lumbar intervertebral disc bulge bone fracture dislocation
08/27/2008CN101249194A Traditional Chinese medicine preparation for curing stomach-ache
08/27/2008CN101249186A Chinese medicine oil solution curing trauma, rheumatalgia and dentalgia
08/27/2008CN101249164A Traditional Chinese medicine preparation for curing diseases of various neck, shoulder, waist and leg pain
08/27/2008CN101249162A Chinese herbal medicine preparations for curing wind dampness waist-leg pain
08/27/2008CN101249152A Preparing method of low toxicity aconitum analgesia preparation
08/27/2008CN101249151A Chinese medicine preparation for treating gout and rheumatism
08/27/2008CN101249147A Catch cold remove heat tablet and method of preparing the same
08/27/2008CN101249144A Harbin pharmaceutical Anghema abdominal pain sticking
08/27/2008CN101249128A Preparation of barren wort total chromocor
08/27/2008CN101249122A Medicament for curing cervical vertebra disease and waist-leg ache and method of preparing the same
08/27/2008CN101249120A Preparations quality control method containing radix dipsaci and pseudo-ginseng activity extracting combination
08/27/2008CN101249119A Compound compound paracetamol and zincgluconate dispersible tablet and method of preparing the same
08/27/2008CN101249115A Double targets extracting technique of caltrop medicinal component
08/27/2008CN101249114A Quality control method of radix dipsaci activity extract
08/27/2008CN101249101A Applications of human placenta interstitial fluid for curing brain and cerebrovascular disease medicament
08/27/2008CN101249079A Andrographolide succinic acid half-ester natrium potassium salt and preparations
08/27/2008CN101248828A Method for preparing reducing fever relieving cough sugar
08/27/2008CN101248809A Method for preparing fresh flower ham (yunnan ham) moon cake
08/27/2008CN100413975C Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product
08/27/2008CN100413961C Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin
08/27/2008CN100413883C Peptidic compounds selectively binding to p-selectin
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413877C Helicid modifier and its preparation method and uses
08/27/2008CN100413864C [1,7]naphthyridines as PDE4 inhibitors
08/27/2008CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/27/2008CN100413850C Chemical compounds
08/27/2008CN100413849C Benzimidazole derivatives
08/27/2008CN100413534C Biological immune preparation for treating dairy cattle clinical mamitis and its manufacturing method
08/27/2008CN100413527C Iron bar spray of Tibetan medicine
08/27/2008CN100413519C Camellia oil
08/27/2008CN100413514C Leaves of cajanus cajan(L.) millsp and extract, formulation and uses thereof
08/27/2008CN100413509C Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor
08/27/2008CN100413501C Transdermal absorptive anemonin plaster
08/27/2008CN100413499C A nanoemulsion medicine of eugenol and preparation method thereof
08/26/2008US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
08/26/2008US7417072 Blockade of Pin1 prevents cytokine production by activated immune cells
08/26/2008US7417058 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end
08/26/2008US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
08/26/2008US7417035 Phospholipid derivatives of non-steroidal anti-inflammatory drugs